The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000653369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
28/04/2026
Date registered
Help: Date registered
2/06/2026
Date last updated
Help: Date last updated
7/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
2/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Peri-operative antibiotic irrigation of bowel lumen in colorectal surgery patients for the prevention of anastomotic leakage: a feasibility study
Scientific title
Peri-operative antibiotic irrigation of bowel lumen in colorectal surgery patients for the prevention of anastomotic leakage: a feasibility study
Additional trial identifiers [1] 317122 0
Nil known
Universal Trial Number (UTN)
Trial acronym
AWASH
Related trial records

Health condition
Health condition(s) studied:
Colorectal cancer 341677 0
Condition category
Condition code
Cancer 337768 337768 0 0
Bowel - Back passage (rectum) or large bowel (colon)
Surgery 337769 337769 0 0
Other surgery

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Arm A: Intra-operative luminal antibiotics of 500mg in 100ml of Metronidazole with 240mg in 6ml Gentamicin. With daily post-operative antibiotic irrigation of Metronidazole 250mg (in 50ml) and Gentamicin 240mg in 6ml.
Participants in Arm A will receive an intra-operative luminal antibiotic wash administered by the treating colorectal surgeon during elective colorectal resection with primary anastomosis. After surgery, participants will receive daily antibiotic irrigation via a rectal tube for up to 2 post-operative days, administered by an appropriately trained registered nurse and/or medical officer. Each post-operative irrigation is expected to take approximately 5–10 minutes per treatment. Adherence will be assessed using the operation note, treatment and nursing records, electronic medical record, and study case report forms documenting delivery of the intra-operative and post-operative components.
Intervention code [1] 333886 0
Treatment: Drugs
Description of the comparator or control
Arm B: Usual care (Standard care is defined as the routine perioperative and post-operative management normally provided to patients undergoing elective colorectal resection with primary anastomosis at the study site, in accordance with local practice and clinician judgement).
Participants in Arm B will receive standard surgical and post-operative care for elective colorectal resection with primary anastomosis, with no intra-operative luminal antibiotic wash and no post-operative antibiotic irrigation via rectal tube. Care will otherwise follow routine site practice. Adherence will be assessed using the operation note, electronic medical record, nursing records and study case report forms documenting that the intervention was not administered.
Control group
Active

Outcomes
Primary outcome [1] 345216 0
Primary outcome 1: Completion of post-operative administration Assessed as whether the required post-operative irrigation doses were administered as per protocol.
Timepoint [1] 345216 0
Intra-operative Days 1 and 2 for patients with a rectal tube in ARMA Day 30 follow-up
Primary outcome [2] 345217 0
Primary outcome 2: Timeliness of post-operative administration Assessed as whether post-operative irrigation was administered within the protocol-specified timeframes.
Timepoint [2] 345217 0
Intra-operative Days 1 and 2 for patients with a rectal tube in ARMA Day 30 follow-up
Secondary outcome [1] 460981 0
Secondary outcome: Time to first flatus Assessed independently as the time from surgery to first reported passage of flatus.
Timepoint [1] 460981 0
Daily from post-operative day 1 to 5
Secondary outcome [2] 460983 0
Anastomotic leak
Timepoint [2] 460983 0
Every day while in the hospital
Secondary outcome [3] 460984 0
Postoperative Ileus
Timepoint [3] 460984 0
Post-operative
Secondary outcome [4] 460985 0
Surgical site infection
Timepoint [4] 460985 0
This assessment will be completed at the day 30 follow-up by reviewing routine clinical documentation up to 30 days after surgery. Vital signs during admission are monitored according to standard post-operative care and hospital protocols. No additional study-specific vital signs monitoring will occur.
Secondary outcome [5] 461294 0
Time to first stool Assessed independently as the time from surgery to first bowel motion.
Timepoint [5] 461294 0
Daily until discharge from hospital

Eligibility
Key inclusion criteria
• Adults greater than or equal to 18 years undergoing elective colorectal resection with primary anastomosis.
• Ability to provide informed consent.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Emergency surgery
• Known allergies to antibiotics
• Existence of a stoma preoperatively
• Inability to provide informed consent
• Pregnant and Breast-feeding women

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Centralised randomisation (via a computer system)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated random numbers
Random number tables
Statistical software (e.g., REDCap randomisation module)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s

The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 29437 0
Calvary Mater Newcastle - Waratah
Recruitment hospital [2] 29438 0
John Hunter Hospital - New Lambton
Recruitment postcode(s) [1] 45757 0
2298 - Waratah
Recruitment postcode(s) [2] 45758 0
2305 - New Lambton

Funding & Sponsors
Funding source category [1] 321706 0
Government body
Name [1] 321706 0
Hunter New England Local Health District
Country [1] 321706 0
Australia
Funding source category [2] 321708 0
Hospital
Name [2] 321708 0
Calvary Mater Newcastle
Country [2] 321708 0
Australia
Primary sponsor type
Hospital
Name
John Hunter hospital
Address
Country
Australia
Secondary sponsor category [1] 324536 0
None
Name [1] 324536 0
None
Address [1] 324536 0
Country [1] 324536 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320238 0
Hunter New England Human Research Ethics Committee
Ethics committee address [1] 320238 0
Ethics committee country [1] 320238 0
Australia
Date submitted for ethics approval [1] 320238 0
16/04/2026
Approval date [1] 320238 0
14/05/2026
Ethics approval number [1] 320238 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149854 0
Prof Stephen Smith
Address 149854 0
Calvary Mater Newcastle Edith St, Waratah NSW 2298
Country 149854 0
Australia
Phone 149854 0
+61 0477340275
Fax 149854 0
Email 149854 0
Contact person for public queries
Name 149855 0
Stephen Smith
Address 149855 0
Calvary Mater Newcastle Edith St, Waratah NSW 2298
Country 149855 0
Australia
Phone 149855 0
+61 0477340275
Fax 149855 0
Email 149855 0
Contact person for scientific queries
Name 149856 0
Stephen Smith
Address 149856 0
Calvary Mater Newcastle Edith St, Waratah NSW 2298
Country 149856 0
Australia
Phone 149856 0
+61 0477340275
Fax 149856 0
Email 149856 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.